Werewolf Therapeutics, Inc.
HOWL
Revenue
0.00
0.000.00%
-Assets
153.70M
▼-23.90M▼-13.46%
3 Months ChangeLiabilities
49.69M
▼-10.33M▼-17.21%
3 Months ChangeFree Cash Flow
-15.41M
▼-5.34M▼-53.07%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0001785530-24-000028
2024-08-08
Form 8-K
ID: 0001785530-24-000026
2024-06-25
Form 8-K
ID: 0001193125-24-167467
2024-06-03
Form 8-K
ID: 0001193125-24-152380
2024-05-28
Form 8-K
ID: 0001193125-24-148114
2024-05-03
Form 10-Q
ID: 0001785530-24-000020
2024-05-03
Form 8-K
ID: 0001785530-24-000018
2024-03-07
Form 8-K
ID: 0001785530-24-000010
2024-02-09
Form 8-K
ID: 0001193125-24-030144
2024-01-08
Form 8-K
ID: 0001193125-24-003937